healthprotocol.wiki

van-anrooij_2018_cohort_midostaurin-in-indolent-systemic-mastocytosis-open-label-phase-2

3 findings

Protocol
medication-midostaurin-twice-daily
Outcome
biomarker-tryptase-serum-decrease
n
20
effect
15
attribution
45
Protocol
medication-midostaurin-twice-daily
Outcome
qol-improvement-overall-perceived-rating-self-reported
n
20
effect
15
attribution
45
Protocol
medication-midostaurin-twice-daily
Outcome
symptom-score-reduction
n
20
effect
15
attribution
45